MR-Guided Laser Ablation of Prostate Bed Recurrences

Not Applicable

Withdrawn

• Conditions: Prostate Tumors

• Registration Number: NCT01743638
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study is to see if MR-guided laser ablation can effectively treat prostate tumor recurrences.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04
• Study First Submitted: 2012-12-04
• Study First Submitted QC: 2012-12-04
• Study First Posted: 2012-12-06
• Primary Completion: 2014-02
• Study Completion: 2014-02
• Status Verified: 2014-04
• Last Update Submitted: 2014-04-09
• Last Update Posted: 2014-04-10

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

• Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa referred to Urology and/or Interventional Radiology for treatment.
• Surgery is not a desirable alternative therapy at the time of enrollment
• Radiation therapy has failed or not indicated or can be safely postponed
• Tumor size ≤ 5 cm at its largest diameter
• Tumor does not encompass the rectal wall or external urethral sphincter
• Performance status is ECOG 2 or better in adults
• Patient is able to undergo MRI

Exclusion Criteria

• Patients with pacemaker or defibrillator

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Measurement of target lesion(s) dimensions at 3-6 month imaging follow-up	3-6 months

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Rochester, Minnesota, United States